AMIKACIN SULFATE INJECTION
Google image searchProduct monograph
Active ingredient
amikacin (amikacin sulfate), 250 MG/ML
DIN: 02529459
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Description: SINGLE-USE VIALS
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 06-OCT-2023
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01G — AMINOGLYCOSIDE ANTIBACTERIALS (ATC, ATC/DDD)
- J01GB — Other aminoglycosides (ATC, ATC/DDD)
- J01GB06 — AMIKACIN (ATC/DDD)
Reference brand drug: Amikin
Pharmaceutical standard: MFR
